Objectives: Probenecid is an anion transport inhibitor, which, according to the connectivity map (CMap; a biological application database), interferes with hypoxia-induced gene expression changes in retinal vascular endothelial cells (ECs). Here, we investigated the influence of probenecid on retinal EC cytotoxicity and retinal neovascularization in a murine oxygen-induced retinopathy (OIR) model.Methods: The retinal EC growth rate in the presence of hypoxia-mimicking concentrations of cobalt chloride (CoCl2) was determined using the thiazolyl blue tetrazolium bromide (MTT) assay and proliferating cell nuclear antigen (PCNA) expression. In OIR rats, probenecid was administered by intraperitoneal injection (i.p.) from postnatal day (P) 1 to ...
PURPOSE. To test whether platelet-activating factor (PAF) directly causes retinovascular endothelial...
PURPOSE: In a mouse model of oxygen-induced retinopathy (OIR), a well-established model of retinopat...
AIM: To study the effects of LY294002 [phosphatidylinositol 3-kinase (PI3K) inhibitor] on the functi...
Purpose: To determine the effects of LY294002, a phosphatidylinositol 3-kinase inhibitor, on suppres...
PURPOSE: To determine whether selective activation or blockade of the somatostatin (SRIF) receptor 2...
Aquaporins (AQPs) are important for regulating cellular water, solute transport, and balance. Recent...
PURPOSE: Oxygen-induced retinopathy (OIR) is a model for human retinopathy of prematurity (ROP). In ...
PURPOSE: Pharmacologic control of neovascularization is a promising approach for the treatment o...
Purpose: Pathological retinal angiogenesis is a major cause of vision loss. Endostatin is a natural ...
PURPOSE: Pharmacologic control of neovascularization is a promising approach for the treatment o...
The present study was undertaken to test whether inhibition of the proangiogenic inflammatory cytoki...
Retinopathy of Prematurity (ROP) is a vasoproliferative retinal disorder that is the leading cause o...
Purpose. Prolyl hydroxylases (PHDs) are oxygen sensors that stabilize hypoxia-inducible factors (HIF...
KH902 is a fusion protein derived from the extracellular domains of vascular endothelial growth fact...
Abstract: Hypoxia-inducible factor-1 (HIF-1) plays crucial roles in retinal neovascularization (NV) ...
PURPOSE. To test whether platelet-activating factor (PAF) directly causes retinovascular endothelial...
PURPOSE: In a mouse model of oxygen-induced retinopathy (OIR), a well-established model of retinopat...
AIM: To study the effects of LY294002 [phosphatidylinositol 3-kinase (PI3K) inhibitor] on the functi...
Purpose: To determine the effects of LY294002, a phosphatidylinositol 3-kinase inhibitor, on suppres...
PURPOSE: To determine whether selective activation or blockade of the somatostatin (SRIF) receptor 2...
Aquaporins (AQPs) are important for regulating cellular water, solute transport, and balance. Recent...
PURPOSE: Oxygen-induced retinopathy (OIR) is a model for human retinopathy of prematurity (ROP). In ...
PURPOSE: Pharmacologic control of neovascularization is a promising approach for the treatment o...
Purpose: Pathological retinal angiogenesis is a major cause of vision loss. Endostatin is a natural ...
PURPOSE: Pharmacologic control of neovascularization is a promising approach for the treatment o...
The present study was undertaken to test whether inhibition of the proangiogenic inflammatory cytoki...
Retinopathy of Prematurity (ROP) is a vasoproliferative retinal disorder that is the leading cause o...
Purpose. Prolyl hydroxylases (PHDs) are oxygen sensors that stabilize hypoxia-inducible factors (HIF...
KH902 is a fusion protein derived from the extracellular domains of vascular endothelial growth fact...
Abstract: Hypoxia-inducible factor-1 (HIF-1) plays crucial roles in retinal neovascularization (NV) ...
PURPOSE. To test whether platelet-activating factor (PAF) directly causes retinovascular endothelial...
PURPOSE: In a mouse model of oxygen-induced retinopathy (OIR), a well-established model of retinopat...
AIM: To study the effects of LY294002 [phosphatidylinositol 3-kinase (PI3K) inhibitor] on the functi...